Relates to prescription forms and labels; requires interpretation services by chain pharmacies and mail order pharmacies for patients with limited English proficiency.
Sponsor: HANNON / Co-sponsor(s): AVELLA, CARLUCCI, DIAZ, DUANE, GRISANTI, KLEIN, MONTGOMERY, PARKER, RIVERA, SAVINO, VALESKY / Committee: HEALTH
Law Section: Public Health Law / Law: Amd S21, Pub Health L; amd SS6810 & 6509, add S6829, Ed L
Sponsor: HANNON / Co-sponsor(s): AVELLA, CARLUCCI, DIAZ, DUANE, GRISANTI, KLEIN, MONTGOMERY, PARKER, RIVERA, SAVINO, VALESKY / Committee: HEALTH
Law Section: Public Health Law / Law: Amd S21, Pub Health L; amd SS6810 & 6509, add S6829, Ed L
S5000-2011 Actions
- Jan 4, 2012: REFERRED TO HEALTH
- Jun 17, 2011: PRINT NUMBER 5000A
- Jun 17, 2011: AMEND AND RECOMMIT TO HEALTH
- May 2, 2011: REFERRED TO HEALTH
S5000-2011 Memo
BILL NUMBER:S5000 TITLE OF BILL: An act to amend the public health law and the education law, in relation to prescription forms and labels, interpretation services and patients with limited English proficiency PURPOSE OF GENERAL IDEA OF BILL: To promote safe and effective use of prescription medications by reducing the barriers many consumers face in trying to understand prescription drug labels, dosage instructions and other vital patient information. SUMMARY OF SPECIFIC PROVISIONS: Section 1 amends § 21 of the Public Health law to require that prescription forms and electronic prescriptions include a section that allows prescribers to indicate whether an individual is limited English proficient and, if so, the preferred language of the patient. Section 2 amends § 6810 of the education law to provide that all prescription labels must conform to the standardization and language accessibility requirements outlined in Education Law § 6829 (see below). Section 3 enacts a new Education Law § 6829 to require chain pharmacies and mail order pharmacies to provide free, competent oral interpretation services to all limited English proficient individuals, particularly during the process of medication counseling and when obtaining information to establish the patient's medication profile. This section also requires the State Board of Pharmacy to develop standardized prescription drug labels to ensure greater comprehension of labels by consumers, improved directions for use, improved font types and sizes, and better placement on medication bottles and requires that the standardized prescription drug labels be translated into the top seven languages spoken by limited English proficient individuals in New York State. Section 4 adds a new subdivision (15) to Education Law § 6509 to make a violation of § 6829 grounds for professional discipline of a pharmacist. Section 5 is the effective date. JUSTIFICATION: Misuse of prescription medications causes over one million "adverse drug events" every year, resulting in visits to the emergency room, hospitalization and, in some cases, even death. One of the reasons such misuse occurs is limited English proficiency among patients. Studies have found that less than half of patients understand the dosage instructions currently provided on prescription medication bottles. Pharmacists often transcribe the same medication instruction in different ways at different times, which can cause confusion for patients, especially those who take many medications such as the elderly. Language barriers and the inability to read or understand medical information in English can pose health risks to patients with limited English proficiency. This legislation aims to reduce the number of medication errors that result from the challenges patients face in comprehending medication labels. By requiring the State Board of Pharmacy to standardize and simplify the content of medication warning and instruction labels, the legislation will ensure that prescription drugs dispensed in New York State are more accessible and understandable to a broad range of consumers. By requiring interpretation services and the translation of standardized medication labels, the legislation will ensure that language does not pose as a barrier to safe and effective use of prescription drugs. Standardizing drug labels will make them easier for patients to understand, reduce errors, and make translating labels easier. PRIOR LEGISLATIVE HISTORY: 2010: A.11627 Referred to Higher Education/S.8365 Referred to Rules FISCAL IMPLICATIONS: None. EFFECTIVE DATE: One year after it shall become law.
S5000-2011 Text
S T A T E O F N E W Y O R K
5000 2011-2012 Regular Sessions I N SENATE May 2, 2011
Introduced by Sen. HANNON -- read twice and ordered printed, and when printed to be committed to the Committee on Health
AN ACT to amend the public health law and the education law, in relation to prescription forms and labels, interpretation services and patients with limited English proficiency THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM BLY, DO ENACT AS FOLLOWS:
Section 1. The opening paragraph of section 21 of the public health law is designated subdivision 1 and a new subdivision 2 is added to read as follows:
2. THE COMMISSIONER SHALL PROMULGATE REGULATIONS REQUIRING THAT PRESCRIPTION FORMS AND ELECTRONIC PRESCRIPTIONS INCLUDE: (A) A SECTION WHEREIN PRESCRIBERS MUST INDICATE WHETHER AN INDIVIDUAL IS LIMITED ENGLISH PROFICIENT; AND (B) IF THE PATIENT IS LIMITED ENGLISH PROFI CIENT, A LINE WHERE THE PRESCRIBER SHALL SPECIFY THE PREFERRED LANGUAGE INDICATED BY THE PATIENT. FOR THE PURPOSES OF THIS SUBDIVISION, A "LIMITED ENGLISH PROFICIENT INDIVIDUAL" MEANS AN INDIVIDUAL WHO IDENTI FIES AS BEING, OR IS EVIDENTLY, UNABLE TO SPEAK, READ OR WRITE ENGLISH AT A LEVEL THAT PERMITS SUCH INDIVIDUAL TO UNDERSTAND HEALTH-RELATED AND PHARMACEUTICAL INFORMATION COMMUNICATED IN ENGLISH.
S 2. Subdivision 1 of section 6810 of the education law, as amended by chapter 905 of the laws of 1985, is amended to read as follows:
1. No drug for which a prescription is required by the provisions of the Federal Food, Drug and Cosmetic Act or by the commissioner of health shall be distributed or dispensed to any person except upon a prescription written by a person legally authorized to issue such prescription. Such drug shall be compounded or dispensed by a licensed pharmacist, and no such drug shall be dispensed without affixing to the immediate container in which the drug is sold or dispensed a label bear ing the name and address of the owner of the establishment in which it was dispensed, the date compounded, the number of the prescription under EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets [ ] is old law to be omitted. LBD02457-05-1
S. 5000 2 which it is recorded in the pharmacist's prescription files, the name of the prescriber, the name and address of the patient, and the directions for the use of the drug by the patient as given upon the prescription. ALL LABELS SHALL CONFORM TO SUCH RULES AND REGULATIONS AS PROMULGATED BY THE STATE BOARD OF PHARMACY PURSUANT TO SECTION SIXTY-EIGHT HUNDRED TWENTY-NINE OF THIS ARTICLE. The prescribing and dispensing of a drug which is a controlled substance shall be subject to additional require ments provided in article thirty-three of the public health law. The words "drug" and "prescription required drug" within the meaning of this article shall not be construed to include soft or hard contact lenses, eyeglasses, or any other device for the aid or correction of vision. Nothing in this subdivision shall prevent a pharmacy from furnishing a drug to another pharmacy which does not have such drug in stock for the purpose of filling a prescription.
S 3. The education law is amended by adding a new section 6829 to read as follows:
S 6829. INTERPRETATION REQUIREMENTS FOR PRESCRIPTION DRUGS AND STAND ARDIZED MEDICATION LABELING. 1. FOR THE PURPOSES OF THIS SECTION, THE FOLLOWING TERMS SHALL HAVE THE FOLLOWING MEANINGS: (A) "CHAIN PHARMACY" MEANS ANY PHARMACY THAT IS PART OF A GROUP OF FOUR OR MORE ESTABLISH MENTS THAT (I) CONDUCT BUSINESS UNDER THE SAME BUSINESS NAME OR (II) OPERATE UNDER COMMON OWNERSHIP OR MANAGEMENT OR PURSUANT TO A FRANCHISE AGREEMENT WITH THE SAME FRANCHISOR. (B) "LIMITED ENGLISH PROFICIENT INDIVIDUAL" OR "LEP INDIVIDUAL" MEANS AN INDIVIDUAL WHO IDENTIFIES AS BEING, OR IS EVIDENTLY, UNABLE TO SPEAK, READ OR WRITE ENGLISH AT A LEVEL THAT PERMITS SUCH INDIVIDUAL TO UNDER STAND HEALTH-RELATED AND PHARMACEUTICAL INFORMATION COMMUNICATED IN ENGLISH. (C) "TRANSLATE" SHALL MEAN THE CONVERSION OF A WRITTEN TEXT FROM ONE LANGUAGE INTO AN EQUIVALENT WRITTEN TEXT IN ANOTHER LANGUAGE BY AN INDI VIDUAL COMPETENT TO DO SO AND UTILIZING ALL NECESSARY PHARMACEUTICAL AND HEALTH-RELATED TERMINOLOGY. (D) "COMPETENT ORAL INTERPRETATION" MEANS ORAL COMMUNICATION IN WHICH (I) A PERSON ACTING AS AN INTERPRETER COMPREHENDS A SPOKEN MESSAGE AND RE-EXPRESSES THAT MESSAGE ACCURATELY IN ANOTHER LANGUAGE, UTILIZING ALL NECESSARY PHARMACEUTICAL AND HEALTH-RELATED TERMINOLOGY; OR (II) A BILINGUAL PHARMACY STAFF MEMBER COMMUNICATES PROFICIENTLY WITH AN LEP INDIVIDUAL IN THE LEP INDIVIDUAL'S PRIMARY LANGUAGE UTILIZING ALL NECES SARY PHARMACEUTICAL AND HEALTH-RELATED TERMINOLOGY. (E) "PHARMACY PRIMARY LANGUAGES" SHALL MEAN THE TOP SEVEN LANGUAGES SPOKEN BY LEP INDIVIDUALS IN THIS STATE AS DETERMINED BIENNIALLY BY THE STATE BOARD OF PHARMACY BASED ON DATA FROM THE MOST RECENT AMERICAN COMMUNITY SURVEY FROM THE U.S. CENSUS BUREAU AND OTHER RELEVANT DATA SOURCES. (F) "MAIL ORDER PHARMACY" SHALL MEAN A PHARMACY THAT DISPENSES MOST OF ITS PRESCRIPTIONS THROUGH THE UNITED STATES POSTAL SERVICE OR OTHER DELIVERY SYSTEM. 2. (A) EVERY CHAIN PHARMACY AND MAIL ORDER PHARMACY SHALL PROVIDE FREE, COMPETENT ORAL INTERPRETATION SERVICES TO EACH LEP INDIVIDUAL FILLING A PRESCRIPTION AT SUCH CHAIN PHARMACY OR THROUGH SUCH MAIL ORDER PHARMACY IN THE LEP INDIVIDUAL'S PRIMARY LANGUAGE FOR THE PURPOSES OF COUNSELING SUCH INDIVIDUAL ABOUT HIS OR HER PRESCRIPTION MEDICATIONS OR WHEN SOLICITING INFORMATION NECESSARY TO MAINTAIN A PATIENT MEDICATION PROFILE, UNLESS THE LEP INDIVIDUAL IS OFFERED AND REFUSES SUCH SERVICES. (B) EVERY CHAIN PHARMACY AND MAIL ORDER PHARMACY SHALL PROVIDE FREE, COMPETENT ORAL INTERPRETATION OF PRESCRIPTION MEDICATION LABELS, WARNING S. 5000 3 LABELS AND OTHER WRITTEN MATERIAL TO EACH LEP INDIVIDUAL FILLING A PRESCRIPTION AT SUCH CHAIN PHARMACY OR THROUGH SUCH MAIL ORDER PHARMACY, UNLESS THE LEP INDIVIDUAL IS OFFERED AND REFUSES SUCH SERVICES OR THE MEDICATION LABEL, WARNING LABELS AND OTHER WRITTEN MATERIALS HAVE ALREADY BEEN TRANSLATED INTO THE LANGUAGE SPOKEN BY THE LEP INDIVIDUAL. (C) THE SERVICES REQUIRED BY THIS SECTION MAY BE PROVIDED BY A STAFF MEMBER OF THE PHARMACY OR A THIRD-PARTY CONTRACTOR. SUCH SERVICES MUST BE PROVIDED ON AN IMMEDIATE BASIS BUT NEED NOT BE PROVIDED IN-PERSON OR FACE-TO-FACE IN ORDER TO MEET THE REQUIREMENTS OF THIS SECTION. 3. EVERY CHAIN PHARMACY SHALL CONSPICUOUSLY POST, AT OR ADJACENT TO EACH COUNTER OVER WHICH PRESCRIPTION DRUGS ARE SOLD, AND EVERY MAIL ORDER PHARMACY SHALL INCLUDE IN THE PACKAGE IN WHICH PRESCRIPTION DRUGS ARE DELIVERED A NOTIFICATION OF THE RIGHT TO FREE LANGUAGE ASSISTANCE SERVICES FOR LIMITED ENGLISH PROFICIENT INDIVIDUALS AS PROVIDED FOR IN SUBDIVISION TWO OF THIS SECTION. SUCH NOTIFICATIONS SHALL BE PROVIDED IN THE PHARMACY PRIMARY LANGUAGES. THE SIZE, STYLE AND PLACEMENT OF SUCH NOTICE SHALL BE DETERMINED IN ACCORDANCE WITH RULES PROMULGATED BY THE STATE BOARD OF PHARMACY. 4. ANY PERSON AGGRIEVED BY A FAILURE TO RECEIVE SERVICES REQUIRED BY THIS SECTION SHALL HAVE A CAUSE OF ACTION ONLY AGAINST THE CHAIN PHARMA CY OR MAIL ORDER PHARMACY IN ANY COURT OF COMPETENT JURISDICTION FOR DAMAGES, INCLUDING PUNITIVE DAMAGES, AND FOR INJUNCTIVE RELIEF AND SUCH OTHER REMEDIES AS MAY BE APPROPRIATE. 5. (A) THE STATE BOARD OF PHARMACY SHALL DEVELOP RULES AND REGULATIONS REQUIRING A STANDARDIZED, PATIENT-CENTERED, PRESCRIPTION DRUG LABEL TO BE USED ON ALL PRESCRIPTION MEDICINE DISPENSED TO PATIENTS IN THIS STATE. (B) WHEN DEVELOPING THE REQUIREMENTS FOR PRESCRIPTION DRUG LABELS, THE STATE BOARD OF PHARMACY SHALL CONSIDER FACTORS INCLUDING, BUT NOT LIMIT ED TO, THE FOLLOWING:
(I) MEDICAL LITERACY RESEARCH THAT POINTS TO INCREASED UNDERSTAND ABILITY OF LABELS; (II) IMPROVED DIRECTIONS FOR USE; (III) IMPROVED FONT TYPES AND SIZES; (IV) PLACEMENT OF INFORMATION THAT IS PATIENT-CENTERED; (V) THE NEEDS OF SENIOR CITIZENS. TO ENSURE MAXIMUM PUBLIC COMMENT, THE STATE BOARD OF PHARMACY SHALL HOLD PUBLIC MEETINGS TO SEEK INFORMATION FROM GROUPS REPRESENTING CONSUMERS, SENIORS, PHARMACISTS OR THE PRACTICE OF PHARMACY, OTHER HEALTH CARE PROFESSIONALS, AND OTHER INTERESTED PARTIES. (C) TWO HUNDRED SEVENTY DAYS AFTER THE STATE BOARD OF PHARMACY HAS ISSUED ITS FINAL RULES AND REGULATIONS REGARDING STANDARDIZED, PATIENT CENTERED PRESCRIPTION MEDICATION LABELS, CHAIN PHARMACIES AND MAIL ORDER PHARMACIES SHALL PROVIDE FREE, COMPETENT TRANSLATED MEDICATION LABELS TO EACH LEP INDIVIDUAL FILLING A PRESCRIPTION AT SUCH CHAIN PHARMACY OR MAIL ORDER PHARMACY WHO SPEAKS ONE OF THE PHARMACY PRIMARY LANGUAGES. NOTHING IN THIS SECTION SHALL PROHIBIT A CHAIN PHARMACY OR MAIL ORDER PHARMACY FROM PROVIDING TRANSLATED MEDICATION LABELS IN LANGUAGES IN ADDITION TO THE PHARMACY PRIMARY LANGUAGES. THE CHAIN PHARMACY OR MAIL ORDER PHARMACY SHALL PROVIDE FREE, COMPETENT ORAL INTERPRETATION OF MEDICATION LABELS TO LEP INDIVIDUALS WHO DO NOT SPEAK ONE OF THE PHARMA CY PRIMARY LANGUAGES, UNLESS THE LEP INDIVIDUAL IS OFFERED AND REFUSES SUCH SERVICES.
S 4.
Section 6509 of the education law is amended by adding a new subdivision 15 to read as follows:
S. 5000 4 (15) A VIOLATION OF SECTION SIXTY-EIGHT HUNDRED TWENTY-NINE OF THIS CHAPTER (INTERPRETATION REQUIREMENTS FOR PRESCRIPTION DRUGS AND STAND ARDIZED MEDICATION LABELING).
S 5. This act shall take effect one year after it shall become a law; provided, however, that the commissioner of health, the commissioner of education and the state board of pharmacy are immediately authorized and directed to take actions necessary to implement this act when it takes effect.

*By contributing or voting you agree to the Terms of Participation and Privacy Policy and verify you are over 13.
Discuss!
blog comments powered by Disqus